These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

505 related items for PubMed ID: 16941248

  • 1. Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images.
    Karabacakoğlu A, Adigüzel Y, Karaköse S, Kayaçetin E, Haykir R.
    Turk J Gastroenterol; 2006 Sep; 17(3):164-71. PubMed ID: 16941248
    [Abstract] [Full Text] [Related]

  • 2. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
    Chung JJ, Kim MJ, Kim KW.
    J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954
    [Abstract] [Full Text] [Related]

  • 3. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
    Wang C.
    Acta Radiol Suppl; 1998 May; 415():1-31. PubMed ID: 9571956
    [Abstract] [Full Text] [Related]

  • 4. Mangafodipir trisodium-enhanced MRI of hepatocellular carcinoma: correlation with histological characteristics.
    Kim JH, Kim MJ, Park YN, Lee JT, Kim BR, Chung JB, Choi JS, Kim KS, Kim KW.
    Clin Radiol; 2008 Nov; 63(11):1195-204. PubMed ID: 18929037
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Detection of neuroendocrine liver metastases with MnDPDP-enhanced MRI.
    Rockall AG, Planche K, Power N, Nowosinska E, Monson JP, Grossman AB, Reznek RH.
    Neuroendocrinology; 2009 Nov; 89(3):288-95. PubMed ID: 19023191
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Benign hepatic tumors: MRI features before and after administration of superparamagnetic contrast media].
    Bartolotta TV, Midiri M, Galia M, Carcione A, De Maria M, Lagalla R.
    Radiol Med; 2001 Apr; 101(4):219-29. PubMed ID: 11398050
    [Abstract] [Full Text] [Related]

  • 12. Using contrast-enhanced MR cholangiography with IV mangafodipir trisodium (Teslascan) to evaluate bile duct leaks after cholecystectomy: a prospective study of 11 patients.
    Vitellas KM, El-Dieb A, Vaswani KK, Bennett WF, Fromkes J, Ellison C, Bova JG.
    AJR Am J Roentgenol; 2002 Aug; 179(2):409-16. PubMed ID: 12130442
    [Abstract] [Full Text] [Related]

  • 13. Contrast-enhanced MRI of the liver with mangafodipir trisodium: imaging technique and results.
    Sahani DV, O'Malley ME, Bhat S, Hahn PF, Saini S.
    J Comput Assist Tomogr; 2002 Aug; 26(2):216-22. PubMed ID: 11884777
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MRI for detection of hepatocellular carcinoma: comparison of mangafodipir trisodium and gadopentetate dimeglumine contrast agents.
    Youk JH, Lee JM, Kim CS.
    AJR Am J Roentgenol; 2004 Oct; 183(4):1049-54. PubMed ID: 15385303
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP).
    Murakami T, Baron RL, Peterson MS, Oliver JH, Davis PL, Confer SR, Federle MP.
    Radiology; 1996 Jul; 200(1):69-77. PubMed ID: 8657947
    [Abstract] [Full Text] [Related]

  • 18. Small (<or= 2 cm) hepatic lesions in colorectal cancer patients: detection and characterization on mangafodipir trisodium-enhanced MRI.
    Kim KW, Kim AY, Kim TK, Park SH, Kim HJ, Lee YK, Park MS, Ha HK, Kim PN, Kim JC, Lee MG.
    AJR Am J Roentgenol; 2004 May; 182(5):1233-40. PubMed ID: 15100125
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Comparison of biphasic spiral CT and MnDPDP-enhanced MRI in the detection and characterization of liver lesions].
    Grimm J, Müller-Hülsbeck S, Blume J, Biederer J, Heller M.
    Rofo; 2001 Mar; 173(3):266-72. PubMed ID: 11293872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.